Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1970 1
1973 1
1974 2
1977 1
1979 1
1981 1
1984 2
1985 2
1988 1
1989 5
1990 1
1991 1
1993 2
1994 2
1997 1
1998 3
1999 1
2003 2
2004 1
2009 1
2013 2
2014 1
2019 1
2020 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
Sánchez-Rovira P, Hirschberg AL, Gil-Gil M, Bermejo-De Las Heras B, Nieto-Magro C. Sánchez-Rovira P, et al. Oncologist. 2020 Dec;25(12):e1846-1854. doi: 10.1634/theoncologist.2020-0417. Epub 2020 Jun 9. Oncologist. 2020. PMID: 32459035 Free PMC article. Clinical Trial.
LESSONS LEARNED: The levels of circulating follicle-stimulating hormone, luteinizing hormone, estriol, estradiol, and estrone remained unchanged after a 12-week treatment with 0.005% estriol vaginal gel in postmenopausal women receiving nonsteroidal ar …
LESSONS LEARNED: The levels of circulating follicle-stimulating hormone, luteinizing hormone, estriol, estradiol, and estro …
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Slomovitz BM, Filiaci VL, Walker JL, Taub MC, Finkelstein KA, Moroney JW, Fleury AC, Muller CY, Holman LL, Copeland LJ, Miller DS, Coleman RL. Slomovitz BM, et al. Gynecol Oncol. 2022 Mar;164(3):481-491. doi: 10.1016/j.ygyno.2021.12.031. Epub 2022 Jan 19. Gynecol Oncol. 2022. PMID: 35063278 Clinical Trial.
Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C. Hirschberg AL, et al. Menopause. 2020 May;27(5):526-534. doi: 10.1097/GME.0000000000001497. Menopause. 2020. PMID: 32049923 Free PMC article. Clinical Trial.
Small oscillations were observed in FSH and LH, which remained within the postmenopausal range. Estriol levels increased initially and normalized by week 12, and estradiol and estrone remained mostly undetectable throughout the study. CONCLUSIONS: Ultra-low d …
Small oscillations were observed in FSH and LH, which remained within the postmenopausal range. Estriol levels increased initially an …
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor()) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S. Donders G, et al. Breast Cancer Res Treat. 2014 Jun;145(2):371-9. doi: 10.1007/s10549-014-2930-x. Epub 2014 Apr 10. Breast Cancer Res Treat. 2014. PMID: 24718774 Free PMC article. Clinical Trial.
Phase I pharmacokinetic (PK) study assessed circulating estrogens in breast cancer (BC) patients on a non-steroidal aromatase inhibitor (NSAI) with vaginal atrophy using vaginal ultra-low-dose 0.03 mg estriol (E3) and Lactobacillus combination vaginal tablets (Gynoflor()). …
Phase I pharmacokinetic (PK) study assessed circulating estrogens in breast cancer (BC) patients on a non-steroidal aromatase inhibitor (NSA …
Bioidentical compounded hormones: a pharmacokinetic evaluation in a randomized clinical trial.
Sood R, Warndahl RA, Schroeder DR, Singh RJ, Rhodes DJ, Wahner-Roedler D, Bahn RS, Shuster LT. Sood R, et al. Maturitas. 2013 Apr;74(4):375-82. doi: 10.1016/j.maturitas.2013.01.010. Epub 2013 Feb 4. Maturitas. 2013. PMID: 23384975 Clinical Trial.
METHODS: We conducted a randomized, blinded, four-arm 16-day clinical trial of forty postmenopausal women assigned to one of three doses of a compounded estrogen cream (Bi-est (80:20); 2.0, 2.5, or 3.0 mg)+compounded oral progesterone 100 mg, or to a conventional estradiol …
METHODS: We conducted a randomized, blinded, four-arm 16-day clinical trial of forty postmenopausal women assigned to one of three doses of …
Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women.
Schubert W, Cullberg G, Edgar B, Hedner T. Schubert W, et al. Maturitas. 1994 Dec;20(2-3):155-63. doi: 10.1016/0378-5122(94)90012-4. Maturitas. 1994. PMID: 7715468 Clinical Trial.
Combined measured estrogens (i.e. 17 beta-estradiol and estrone) also increased significantly. The relationship between the AUCs for 17 beta-estradiol and estrone was not altered by juice intake indicating that a metabolic step after estrone, i. …
Combined measured estrogens (i.e. 17 beta-estradiol and estrone) also increased significantly. The relationship between the AU …
Effects of fetal sex and dexamethasone on preterm maternal serum concentrations of human chorionic gonadotropin, progesterone, estrone, estradiol, and estriol.
Haning RV Jr, Curet LB, Poole WK, Boehnlein LM, Kuzma DL, Meier SM. Haning RV Jr, et al. Am J Obstet Gynecol. 1989 Dec;161(6 Pt 1):1549-53. doi: 10.1016/0002-9378(89)90924-1. Am J Obstet Gynecol. 1989. PMID: 2690631 Clinical Trial.
There was no significant difference between male- and female-bearing pregnancies for progesterone, cortisol, estrone, estradiol, estriol, or gestational age. In 19 placebo-treated pregnancies and 14 dexamethasone-treated pregnancies with a mean gestational ag …
There was no significant difference between male- and female-bearing pregnancies for progesterone, cortisol, estrone, estradiol …
Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women.
Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR. Reichman ME, et al. J Natl Cancer Inst. 1993 May 5;85(9):722-7. doi: 10.1093/jnci/85.9.722. J Natl Cancer Inst. 1993. PMID: 8478958 Clinical Trial.
In the peri-ovulatory phase, there were increases of 21.2% (P = .01) in plasma estrone levels, 27.5% (P = .01) in plasma estradiol levels, and 31.9% (P = .009) in urinary estradiol levels. In the luteal phase, urinary estrone levels rose 15.2% (P = .05 …
In the peri-ovulatory phase, there were increases of 21.2% (P = .01) in plasma estrone levels, 27.5% (P = .01) in plasma estradiol …
The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women.
Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. Smith AJ, et al. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64. doi: 10.1158/1055-9965.EPI-12-1325. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23652373 Free PMC article. Clinical Trial.
METHODS: Sedentary, healthy, young eumenorrheic women were randomized into an intervention of 30 minutes of moderate-to-vigorous aerobic exercise five times a week for approximately 16 weeks (n = 212), or into a usual-lifestyle sedentary control group (n = 179). Urinary levels of …
METHODS: Sedentary, healthy, young eumenorrheic women were randomized into an intervention of 30 minutes of moderate-to-vigorous aerobic exe …
Effect of ampicillin administration on plasma conjugated and unconjugated estrogen and progesterone levels in pregnancy.
Adlercreutz H, Martin F, Lehtinen T, Tikkanen MJ, Pulkkinen MO. Adlercreutz H, et al. Am J Obstet Gynecol. 1977 Jun 1;128(3):266-71. doi: 10.1016/0002-9378(77)90620-2. Am J Obstet Gynecol. 1977. PMID: 324286 Clinical Trial.
Similar changes were seen in plasma conjugated estrone and estradiol levels, but the effect seemed to be more prolonged. ...Ampicillin caused no consistent change in the plasma levels of unconjugated estrone, estradiol, and estriol or in plasma …
Similar changes were seen in plasma conjugated estrone and estradiol levels, but the effect seemed to be more prolonged. ...Am …
41 results